Advertisement

Topics

Do You Have INFI And These 6 Other Pharma Stocks In Your Portfolio?

07:31 EST 10 Nov 2017 | RTTNews

Infinity Pharmaceuticals Inc. (INFI) has reported encouraging monotherapy dose escalation clinical and translational data from phase 1/1b study of IPI-549 in advanced solid tumors.

Original Article: Do You Have INFI And These 6 Other Pharma Stocks In Your Portfolio?

NEXT ARTICLE

More From BioPortfolio on "Do You Have INFI And These 6 Other Pharma Stocks In Your Portfolio?"

Advertisement
Quick Search
Advertisement
Advertisement